Fifteen Million Against the Model: The Chairman Buys Kinder Morgan

A week ago the insider tape was silent. This week it has one very loud name on it — and it is a name our own scorecard ranks near the bottom of the market.

On Friday, 6 November, Richard D. Kinder — director, 10 percent owner and Executive Chairman of Kinder Morgan (KMI) — bought 500,000 shares in the open market at $29.9884 a share, a purchase worth $14,994,200, disclosed on Form 4 the same day. The Insider Digest flags it as a high-conviction single: a near-$15 million open-market purchase by the company's most senior insider. It is, by a wide margin, the largest insider buy on the current tape.

The filing, at true scale

Scale cuts both ways with a buyer this large, so here it is plainly. After the purchase, Kinder's reported position stands at 246,712,353 shares. The $14.99 million buy therefore adds roughly 0.2% to a stake he already held as a filed 10 percent owner. This is not a founder building a position from nothing; it is a founder adding, in size and at market, to one he has held for years.

What makes the trade the signal anyway is the combination the digest's scoring is built on: the dollar size ($14.99 million is the largest single open-market buy in the current 14-day window), the seniority of the buyer (Executive Chairman, not a junior officer), the method (an open-market purchase, Form 4 code P — the only transaction type the digest counts as a buy signal), and the freshness (transacted and filed on 6 November). On the digest's 14-day leaderboard, only three names show any open-market buying at all: Accenture at $3.20 million, Kinder Morgan at $14.99 million, and Taiwan Semiconductor at $371 thousand. Kinder's purchase alone is about 81% of all the insider buying on that board, against zero dollars sold in the same window for any of the three names. Kinder Morgan's fourth-quarter insider statistics underline how unusual the print is for this company: one open-market purchase against one sale so far in Q4, after a prior quarter with zero purchases and four sales.

What the scorecard says about the same stock

Here is the tension, and it is the reason this trade is worth a note rather than a shrug. In the latest Altamira KPI Scorecard (edition of 9 November, prices as of the 6 November close, 515 companies scored), Kinder Morgan ranks 451st of 515, with a total score of 37.9 — Tier 4, grade D. The total is 0.70 × a fundamental score of 42.2 plus 0.30 × a technical score of 27.8.

The named-KPI picture behind that rank:

• Pillars: value 69.6 is the only pillar above 50. Quality scores 41.5, growth 22.0, shareholder returns 41.6, financial health 27.3, moat 45.1. The dataset's weakness list for KMI names all six areas — quality, growth, shareholder, health, moat and technical.
• Quality-control gate: NOT QUALIFIED — KMI passes 5 of the scorecard's 13 QC criteria.
• Growth record: revenue compounded at +8.1% a year over five years but −4.7% over the most recent three; free cash flow compounded at +0.3% over five years and −4.8% over three. Return on invested capital averages 5.3% over five years.
• Balance sheet: net debt of 4.32× EBITDA, interest coverage of 2.67×, debt-to-equity of 1.04× — the health pillar's 27.3 is the arithmetic consequence.
• Cash return: the dividend yields 3.96% at a payout ratio of 73.1%, with dividend growth of just 2.3% a year over five years. Free cash flow yield is 4.62%, and the shares trade at 19.2× next-twelve-month earnings.
• Valuation: at the $29.96 close on 6 November, the shares sit at a +3.4% margin of safety to fair value of $31.00 — essentially at fair value, not at a discount that explains a $15 million buy on valuation alone.
• Technicals: RSI-14 of 31.7, a 3-month return of −4.6%, a 6-month relative-strength rank of 30, and a price 6.8% below its 200-day average of $32.15 (the 50-day average is $32.07). The stock is 13.9% below its 52-week high and 15.6% above its 52-week low, meeting 2 of 6 Minervini trend criteria.

Kinder bought at $29.9884 — effectively the 6 November close, below both moving averages, and about 3.3% under fair value. In other words, the chairman did not buy strength, a breakout, or a deep discount. He bought a statistically weak, technically washed-out, fairly valued pipeline company — his own — at size. Insider purchases of this size by the person who knows the asset base best are precisely the data point a fundamentals model cannot generate for itself; the model can only note that its growth, health and quality pillars (22.0, 27.3, 41.5) describe a different company from the one its chairman just paid $15 million to own more of.

The rest of the tape

Two forming signals sit underneath the headline, and neither has completed:

• Taiwan Semiconductor (TSM) moved to forming status: director Michael R. Splinter bought 840 shares at $357.00 on 5 November ($299,880, an 11.1% increase in his reported position), joining VP Yuan Lipen's 1,000-share purchase on 1 November ($71,490). Two distinct buyers and $371 thousand in 14 days — one more distinct buyer inside the window would make it a cluster. It appears here only as a supporting fact; the amounts are two orders of magnitude smaller than KMI's.
• Accenture (ACN) remains forming — and is expiring uncompleted. Its two buyers (Chair and CEO Julie Spellman Sweet, $3.00 million across two tranches, and director Paula A. Price, $199,848) both transacted on 26 October. Today's digest still lists ACN as forming with $3.20 million bought, but the 14-day window from 26 October reaches its end around 9 November with no third buyer filed. The scorecard context has not changed: ACN scores 68.2 (Tier 3) with growth its named weakness at 26.1, against shareholder and health pillars of 88.8 and 91.2, and the insider purchase prices of $245–$250 sit above fair value of $223.00 even after the stock's run to a $260.50 close.

Elsewhere: there are no active clusters and no notable sales in today's edition. The cluster-selling warnings persist in the background — Netflix with 4 distinct sellers and $3.94 million sold over 14 days, CrowdStrike with 3 sellers and $30.42 million — broad officer selling that the digest itself cautions is often vest-cycle flow rather than a coordinated exit. Congressional disclosures added 9 newly reported trades, all in the $1,001–$15,000 range band and leaning to sales; given the STOCK Act's disclosure lag of up to roughly 45 days and the fact that amounts are ranges, that is corroborating sentiment, not a timing signal.

Verdict

On the named evidence: this is the strongest insider-buy signal of the season so far — a $14.99 million open-market purchase, by an Executive Chairman, filed the same day, in a tape where total buying across every other name is $3.57 million. Set against it, the scorecard's verdict on the same company is unambiguous and is not softened here: rank 451 of 515, Tier 4, 5 of 13 QC criteria passed, growth pillar 22.0, health pillar 27.3, net debt 4.32× EBITDA, and a margin of safety of only +3.4% at the buy price's close. Both facts are true at once, and the note's claim is only this: when the two disagree, the disagreement itself is the information. What would resolve it is observable — a second KMI insider joining inside a fresh 14-day window (which would build a cluster), follow-on purchases by Kinder himself, or, on the model's side, any improvement in the growth and health pillars that currently anchor the rank. Accenture's forming signal, by contrast, should now be treated as lapsed unless a new filing restarts its clock, and TSM's forming signal completes only if a third distinct buyer appears while its window (1–5 November) is still open.

Sources: Insider Digest edition of 9 November 2026 (Form 4 data via FMP; SEC EDGAR filings for Kinder Morgan — filed 6 November 2026 — and Taiwan Semiconductor — filed 9 November 2026; congressional disclosures via Senate and House feeds); Altamira KPI Scorecard, External 516 edition of 9 November 2026, prices as of the 6 November 2026 close. Fair value is stated as published in the scorecard. This note is research commentary on public filings and published scorecard data, not a recommendation.